Natascia Corti

722 total citations
18 papers, 358 citations indexed

About

Natascia Corti is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Natascia Corti has authored 18 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Epidemiology and 6 papers in Pharmacology. Recurrent topics in Natascia Corti's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Tuberculosis Research and Epidemiology (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Natascia Corti is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Tuberculosis Research and Epidemiology (4 papers) and Antibiotic Resistance in Bacteria (4 papers). Natascia Corti collaborates with scholars based in Switzerland, United States and Uganda. Natascia Corti's co-authors include Peter Pfister, Ada Yonath, Erik C. Böttger, Raz Zarivach, Christian M. Bruell, Alain Rudiger, Sven N. Hobbie, Daniel J. Müller, Gerd A. Kullak‐Ublick and Katharina Rentsch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Natascia Corti

18 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Natascia Corti Switzerland 14 111 91 87 79 65 18 358
Cumhur Y. Demirkale United States 10 58 0.5× 67 0.7× 174 2.0× 84 1.1× 98 1.5× 19 488
Patrizia Morelli Italy 13 28 0.3× 177 1.9× 71 0.8× 42 0.5× 61 0.9× 29 504
Csaba Fehér Spain 14 157 1.4× 44 0.5× 190 2.2× 119 1.5× 180 2.8× 23 482
Robert Lawatscheck Germany 14 45 0.4× 79 0.9× 72 0.8× 28 0.4× 34 0.5× 31 519
Tim Jensen Denmark 11 89 0.8× 139 1.5× 139 1.6× 24 0.3× 163 2.5× 13 614
Leila Hergafi Tunisia 6 153 1.4× 66 0.7× 126 1.4× 15 0.2× 201 3.1× 8 362
Anna Hume United States 9 29 0.3× 55 0.6× 69 0.8× 32 0.4× 63 1.0× 20 372
Janet Wu United States 8 94 0.8× 40 0.4× 91 1.0× 97 1.2× 108 1.7× 13 360
Vasiliki Gennimata Greece 12 95 0.9× 59 0.6× 136 1.6× 26 0.3× 207 3.2× 19 488
J. P. Bédos France 14 101 0.9× 35 0.4× 294 3.4× 125 1.6× 98 1.5× 32 556

Countries citing papers authored by Natascia Corti

Since Specialization
Citations

This map shows the geographic impact of Natascia Corti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natascia Corti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natascia Corti more than expected).

Fields of papers citing papers by Natascia Corti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natascia Corti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natascia Corti. The network helps show where Natascia Corti may publish in the future.

Co-authorship network of co-authors of Natascia Corti

This figure shows the co-authorship network connecting the top 25 collaborators of Natascia Corti. A scholar is included among the top collaborators of Natascia Corti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natascia Corti. Natascia Corti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Leuppi-Taegtmeyer, Anne, Laurent A. Décosterd, Michael Osthoff, et al.. (2018). Multicenter Population Pharmacokinetic Study of Colistimethate Sodium and Colistin Dosed as in Normal Renal Function in Patients on Continuous Renal Replacement Therapy. Antimicrobial Agents and Chemotherapy. 63(2). 15 indexed citations
3.
Sekaggya‐Wiltshire, Christine, Barbara Castelnuovo, Amrei von Braun, et al.. (2017). Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study. BMJ Open. 7(9). e014679–e014679. 8 indexed citations
4.
Corti, Natascia, et al.. (2017). Dexmedetomidine-Associated Hyperthermia: A Series of 9 Cases and a Review of the Literature. Anesthesia & Analgesia. 125(6). 1898–1906. 18 indexed citations
5.
Hoppe, Liesa Katharina, et al.. (2016). Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation. European Journal of Clinical Pharmacology. 72(7). 859–867. 22 indexed citations
6.
Xu, Xiaoying, Dmytro Khadzhynov, Harm Peters, et al.. (2016). Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy. British Journal of Clinical Pharmacology. 83(3). 498–509. 22 indexed citations
7.
Müller, Daniel J., et al.. (2015). Therapeutic Drug Monitoring of Daptomycin. Therapeutic Drug Monitoring. 37(5). 634–640. 25 indexed citations
8.
9.
Sekaggya‐Wiltshire, Christine, Mohammed Lamorde, Alexandra U. Scherrer, et al.. (2014). Low isoniazid and rifampicin concentrations in TB/HIV co‐infected patients in Uganda. Journal of the International AIDS Society. 17(4S3). 19585–19585. 8 indexed citations
10.
Jacomella, Vincenzo, Natascia Corti, & Marc Husmann. (2013). Novel anticoagulants in the therapy of peripheral arterial and coronary artery disease. Current Opinion in Pharmacology. 13(2). 294–300. 13 indexed citations
11.
Corti, Natascia, Alain Rudiger, Alessandro Chiesa, et al.. (2013). Pharmacokinetics of Daily Daptomycin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy. Chemotherapy. 59(2). 143–151. 17 indexed citations
12.
Frei, Pascal, Elisabeth I. Minder, Natascia Corti, et al.. (2012). Liver Transplantation because of Acute Liver Failure due to Heme Arginate Overdose in a Patient with Acute Intermittent Porphyria. Case Reports in Gastroenterology. 6(1). 190–196. 18 indexed citations
13.
Schuler, Pia, Laurent Haegeli, Ardan M. Saguner, et al.. (2012). Predictors of Appropriate ICD Therapy in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy: Long Term Experience of a Tertiary Care Center. PLoS ONE. 7(9). e39584–e39584. 28 indexed citations
14.
Taegtmeyer, Anne B., et al.. (2011). Electronic prescribing increases uptake of clinical pharmacologists' recommendations in the hospital setting. British Journal of Clinical Pharmacology. 72(6). 958–964. 11 indexed citations
15.
Franzen, Daniel, et al.. (2010). Trimethoprim/Sulfamethoxazole Pharmacokinetics in Two Patients Undergoing Continuous Venovenous Hemodiafiltration. Annals of Pharmacotherapy. 44(10). 1669–1672. 15 indexed citations
16.
Corti, Natascia, Katharina Rentsch, Walter Zingg, et al.. (2009). Effect of ritonavir on the pharmacokinetics of the benzimidazoles albendazole and mebendazole: an interaction study in healthy volunteers. European Journal of Clinical Pharmacology. 65(10). 999–1006. 19 indexed citations
17.
Berisio, Rita, Natascia Corti, Peter Pfister, Ada Yonath, & Erik C. Böttger. (2006). 23S rRNA 2058A→G Alteration Mediates Ketolide Resistance in Combination with Deletion in L22. Antimicrobial Agents and Chemotherapy. 50(11). 3816–3823. 22 indexed citations
18.
Pfister, Peter, Natascia Corti, Sven N. Hobbie, et al.. (2005). 23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G. Proceedings of the National Academy of Sciences. 102(14). 5180–5185. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cumhur Y. Demirkale Breakdown of academic impact, for papers by Patrizia Morelli Breakdown of academic impact, for papers by Csaba Fehér Breakdown of academic impact, for papers by Robert Lawatscheck Breakdown of academic impact, for papers by Tim Jensen Breakdown of academic impact, for papers by Leila Hergafi Breakdown of academic impact, for papers by Anna Hume Breakdown of academic impact, for papers by Janet Wu Breakdown of academic impact, for papers by Vasiliki Gennimata Breakdown of academic impact, for papers by J. P. Bédos
Rankless by CCL
2026